Drug intelligence / Profile preview

almond

Development stage: Unknown
Lead developer: ALK Abelló
Modality: Sublingual Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics, Subcutaneous Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics
Administration: Oral, Topical, Intradermal, Percutaneous

Overview

Almond is primarily used in two forms in medical contexts: as an allergenic extract for allergy testing and as a dietary supplement. Sweet almonds are commonly consumed as food and contain fiber, fatty acids, and plant compounds that may help lower cholesterol and regulate blood sugar. Bitter almonds contain amygdalin, which converts to poisonous hydrocyanic acid (HCN) in the body, making them toxic when consumed. Sweet almond oil has been studied for topical use in conditions like stretch marks.

Other names: AlmondAlmond allergenic extractSweet almondBitter almond

Beyond the preview

Go deeper on almond.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on almond.

Explore the full profile